Special Article 1, Issue 13.4
How an AADSM Member Effectively Advocated for Coverage Changes in West Virginia
http://dx.doi.org/10.15331/jdsm.7474
Disclaimer: The use, mention or depiction of any product, device, service or appliance shall not be interpreted as an endorsement, recommendation or preference by the AADSM. Any opinion expressed is solely the opinion of the individual, and not that of the AADSM.AADSM member Dr. Luke Bauserman recently shared his work addressing a coverage issue in West Virginia related to oral appliance therapy (OAT) that impacted approximately 230,000 people, about 13% of West Virginia's population covered under the state's Public Employees Insurance Agency (PEIA). Here's what he had to say:
WHAT DID YOU SEE OCCURRING IN WEST VIRGINIA, AND HOW DID YOU FIX IT?
The Medicare DMEPOS Fee Schedule files show that E0486 (custom-fabricated mandibular advancement device) is assigned a $0 payment ceiling and $0 payment floor. This does not mean that Medicare does not cover oral appliances. Rather, there is no national pricing for E0486 because the code is contractor priced.
The problem is that insurance plans may use Medicare’s national fee schedule as a starting point when building their own payment systems, copying the $0.00 without realizing it wasn’t an actual reimbursement rate.
This is what happened with West Virginia’s PEIA. Although oral appliance therapy was technically covered, providers would receive no payment.
To fix this issue, I reached out directly to PEIA’s leadership and explained what was happening. I shared pricing examples from other federal programs, including TRICARE and the VA, to demonstrate a reasonable reimbursement rate. PEIA quickly updated its fee schedule, made the change retroactive, and corrected past claims. It was a good example of how sharing the right information with the right people can solve a problem (Table 1).
WHY IS ORAL APPLIANCE THERAPY ACCESS IN WEST VIRGINIA SO IMPORTANT?
OAT access is important, especially in West Virginia, due to a variety of factors. Nationally, obstructive sleep apnea is estimated to impact about 83.7 million U.S. adults aged 20 and older – approximately 32.4% of the adult population, of whom roughly 80% remain undiagnosed1. West Virginia carries a disease burden positioned at the upper extreme of the national distribution and ranks among the worst in the nation for adult obesity, hypertension, ischemic heart disease, and stroke – all conditions with well-established bidirectional relationships with OSA. Despite this, sleep-disordered breathing is dramatically underrecognized in the population most likely to harbor it. An analysis of West Virginia Medicaid claims data — a different population, but the best available state-level estimate — found that only 8.8% of adult enrollees carried a sleep-disordered breathing diagnostic code, against a conservatively estimated true prevalence of 25%2.OAT is uniquely positioned to address several West Virginia-specific access barriers that constrain CPAP delivery. Rural geography can limit both initial DME setup and ongoing supply replacement. Electricity reliability, while generally adequate, is a meaningful concern in flood-prone and storm-prone areas. Patient privacy and bedroom-sharing dynamics in multigenerational households may reduce CPAP acceptance. And cost — the barrier most consistently documented in this population — falls heaviest on West Virginians, who face low household incomes, high uninsurance rates, and limited disposable income for resupply costs that accumulate indefinitely. A custom oral appliance is a one-time fabrication with episode adjustment visits; it does not require electricity, masks, hoses, filters, or distilled water.
Also, the demographic profile here is exactly that of the population for which combination and alternative therapies have the strongest equity argument. Recent physiologic and randomized trial data demonstrate that oral appliances combined with CPAP can lower the CPAP pressure required for therapeutic effect, expanding tolerability3, and that mandibular advancement devices are non-inferior to CPAP for blood pressure outcomes in select populations4. Head-to-head trials also show comparable real-world effectiveness between the two therapies5. The dental sleep medicine literature is mature; the access infrastructure is not.
Lastly, West Virginia carries a disproportionate veteran population with elevated OSA risk and higher rates of CPAP intolerance. Approximately 7.3% of West Virginia's civilian population aged 18 and over are veterans, compared with approximately 6.2% nationally6. Veterans with PTSD – a population concentrated in this state – exhibit CPAP adherence rates of approximately 40%, compared with approximately 70% in the general population, with claustrophobia and anxiety identified as the primary barriers7. CPAP intolerance is a guidelines-recognized indication for OAT8, which makes oral appliances a particularly important alternative pathway for the West Virginia veteran population specifically. The Department of Defense and the VA have formally recognized oral appliances as a first-line treatment for mild-to-moderate sleep apnea in their updated 2025 clinical guidelines9, providing federal precedent that strengthens the case for OAT access at every state-level payer.
WHAT CHANGED AFTER THIS ISSUE WAS CORRECTED?
Once the fee schedule was fixed, about 230,000 West Virginians, roughly 13% of the state, gained a functioning, payable benefit. This was a major step forward for public health in West Virginia.WHAT WOULD YOU SAY TO OTHERS WHO WANT TO MAKE A DIFFERENCE IN HEALTHCARE IN THEIR COMMUNITIES?
That a single dental sleep medicine provider, without institutional backing, legislative support, or formal advocacy organization can make a difference in your community. The big takeaway is if you see a problem, don’t be afraid to reach out directly to the people who can fix it. Bring clear evidence, be persistent, and frame the issue as something that can be solved together. Real change can happen quickly when you connect with the right people and present a practical solution. One person’s advocacy can open doors for thousands.
Table 1 — Compressed Advocacy Timeline.
Compressed advocacy timeline summarizing the seven-week intervention from initial LinkedIn outreach (September 4, 2024) through full retroactive claim adjustment (October 22, 2024).
Date | Event |
|---|---|
September 4, 2024 | LinkedIn outreach to PEIA Senior Director regarding the $0.00 allowable for E0486. |
September 23, 2024 | The author suggests that the main cause is likely a gap in coverage and provides reference rate information from TRICARE and the VA. |
September 25–27, 2024 | PEIA Medical Director engages directly; clarification exchange regarding the distinction between coverage and reimbursement; Medical Director confirms diagnosis. |
October 1, 2024 | PEIA Director of Operations establishes a defensible regional rate for E0486; claims administrator notified to update the fee schedule and review all claims previously reimbursed at $0.00. |
October 4, 2024 | K1027, the custom fabricated non-hinged oral device code, set at parity with E0486 |
October 18, 2024 | Author flags first post-correction claim returning at the prior allowable; claims administrator implementation lag identified. |
October 22, 2024 | Claims administrator loads corrected fee schedule entry; all affected claims adjusted retroactively. Total elapsed time from cold outreach to full resolution: 48 days. |
ABBREVIATIONS
AADSM: American Academy of Dental Sleep MedicineCPAP: Continuous positive airway pressure
DME: Durable Medical Equipment
DMEPOS: Durable Medical Equipment, Prosthetics, Orthotics, and Supplies
OAT: Oral appliance therapy
OSA: Obstructive sleep apnea
PEIA: Public Employees Insurance Agency (West Virginia)
PTSD: Post-traumatic stress disorder
VA: U.S. Department of Veterans Affairs
CITATION
REFERENCES
1. Sönmez I, Dupuy AV, Yu KS, Cronin J, Yee J, Azarbarzin A. Unmasking obstructive sleep apnea: estimated prevalence and impact in the United States. Respir Med. 2025;248:108348. doi:10.1016/j.rmed.2025.108348
2. Stansbury R, Strollo P, Pauly N, Sharma I, Schaaf M, Aaron A, Feinberg J. Underrecognition of sleep-disordered breathing and other common health conditions in the West Virginia Medicaid population: a driver of poor health outcomes. J Clin Sleep Med. 2022;18(3):817-824. doi:10.5664/jcsm.9692
3. Tong BK, Tran C, Ricciardiello A, Donegan M, Chiang AKI, Szollosi I, Amatoury J, Carberry JC, Eckert DJ. CPAP combined with oral appliance therapy reduces CPAP requirements and pharyngeal pressure swings in obstructive sleep apnea. J Appl Physiol. 2020;129(5):1085-1091. doi:10.1152/japplphysiol.00393.2020
4. Ong CWL, et al. Mandibular advancement vs CPAP for blood pressure reduction in patients with obstructive sleep apnea. J Am Coll Cardiol. 2024;83(18):1760-1772. doi:10.1016/j.jacc.2024.03.359
5. Hamoda MM, Huynh N, Ayas NT, Rompré P, Bansback N, Massé J-F, Arcache P, Lavigne G, Series F, Fleetham JA, Almeida FR. Continuous positive airway pressure and mandibular advancement splints: the CHOICE multicentre, open-label randomised clinical trial. Eur Respir J. 2025;65(4):2401100. doi:10.1183/13993003.01100-2024
6. U.S. Census Bureau. Veteran status. American Community Survey 5-Year Estimates, Subject Table S2101. 2024. https://data.census.gov/table/ACSST5Y2024.S2101
7. El-Solh AA, Ayyar L, Akinnusi M, Relia S, Akinnusi O. Positive airway pressure adherence in veterans with posttraumatic stress disorder. Sleep. 2010;33(11):1495-1500. doi:10.1093/sleep/33.11.1495
8. Ramar K, Dort LC, Katz SG, et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med. 2015;11(7):773-827. doi:10.5664/jcsm.4858
9. VA/DoD Clinical Practice Guideline for the Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea. Version 2.0. Washington, DC: Department of Veterans Affairs, Department of Defense; 2025.